Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

(2017) Fernando Magro et al.   Journal of Crohns & Colitis

Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis

(2016) S Sahami et al.   United European Gastroenterology Journal

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients

(2015) E. Safroneeva et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohnʼs Disease

(2015) Maike Anna Michaels et al.   INFLAMMATORY BOWEL DISEASES

Predictors of Outcome in Ulcerative Colitis

(2015) Matti Waterman et al.   INFLAMMATORY BOWEL DISEASES

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease

(2015) Peter L. Lakatos et al.   Journal of Crohns & Colitis

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]

(2015) Maria Papp et al.   Journal of Crohns & Colitis

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease

(2015) Nora Sipeki et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Serological studies in inflammatory bowel disease

(2014) Maria Papp et al.   CURRENT OPINION IN GASTROENTEROLOGY

Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis

(2014) David Kevans et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk

(2014) U. Navaneethan   Gastroenterology Report

Circulating Antibodies against Bacterial Wall Products: Are There Arguments for Early Immunosuppression?

(2013) Florian Rieder et al.   DIGESTIVE DISEASES

Serum Antibodies Associated with Complex Inflammatory Bowel Disease

(2013) Abdul A. Elkadri et al.   INFLAMMATORY BOWEL DISEASES

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis

(2013) Maria Papp et al.   JOURNAL OF HEPATOLOGY

Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease

(2012) Polychronis Pavlidis et al.   Clinical & Developmental Immunology

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

(2012) Gert Van Assche et al.   Journal of Crohns & Colitis

Serologic Antiglycan Antibodies in Inflammatory Bowel Disease

(2011) Peter Laszlo Lakatos et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review

(2011) Lani Prideaux et al.   INFLAMMATORY BOWEL DISEASES

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?

(2010) Maria Papp et al.   PLoS One

The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

(2009) Corinne Gower-Rousseau et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

(2009) M. Papp et al.   Clinical and Vaccine Immunology

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

(2009) C H Seow et al.   GUT

p-ANCAs in autoimmune liver disorders recognise human  -tubulin isotype 5 and cross-react with microbial protein FtsZ

(2009) B. Terjung et al.   GUT

Risk factors and characteristics of extent progression in ulcerative colitis

(2009) María Josefina Etchevers et al.   INFLAMMATORY BOWEL DISEASES

Serum anti-glycan antibodies predict complicated Crohnʼs disease behavior

(2009) Florian Rieder et al.   INFLAMMATORY BOWEL DISEASES

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

(2008) James D. Lewis et al.   INFLAMMATORY BOWEL DISEASES

Predictive Value of Serologic Markers in a Population-based Norwegian Cohort with Inflammatory Bowel Disease

(2008) Inger Camilla Solberg et al.   INFLAMMATORY BOWEL DISEASES

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

(2008) Inger Camilla Solberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

(2007) Ole Høie et al.   Journal of Crohns & Colitis